Global Next-Generation Antibody Therapies Market Forecast 2017-2027
NEW YORK, July 5, 2017 /PRNewswire/ -- Report Details
The global next-generation antibody therapies market is expected to grow at a CAGR of 35.9% in the first half of the forecast period. The market is expected to grow at a CAGR of 22.4% from 2016-2027. The market is estimated at $3.1bn in 2016 and $14.1bn in 2021.
Read the full report: http://www.reportlinker.com/p04974737/Global-Next-Generation-Antibody-Therapies-Market-Forecast.html
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 249-page report you will receive 133 charts – all unavailable elsewhere.
The 249-page report provides clear detailed insight into the global next-generation antibody therapies market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Next-Generation Antibody Therapies Market forecasts from 2017-2027
• Along with revenue prediction for the overall world market for next-generation antibody therapies, our investigation shows forecasts to 2027 for the following five submarkets:
- Antibody-drug conjugates (ADCs)
- Engineered antibodies
- Bispecific antibodies
- Antibody fragments and antibody-like proteins (ALPs)
- Biosimilar antibody therapies
• How will leading next-generation antibody therapies perform to 2027 at world level? Our study forecasts individual revenues of seven products:
- Adcetris
- Kadcyla
- Gazyva/Gazyvaro
- Poteligeo
- Removab
- Blincyto
- Kalbitor
• Our analyses show individual revenue forecasts to 2027 for these regional markets:
- US
- EU5 group
- Asia-Pacific region
- Latin America
- Rest of the World
• This report discusses issues affecting the next-generation antibody therapies market:
- R&D for next generation antibodies - explore technologies and potentials
- Challenges with current monoclonal antibody (mAb) therapies
- Big pharma companies investing in next-generation antibody research and development
Read the full report: http://www.reportlinker.com/p04974737/Global-Next-Generation-Antibody-Therapies-Market-Forecast.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article